Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07725445
NA

Evaluation of an AI-Based Lightweight ECG Telemetry Monitoring System

Sponsor: HUINNO Co., Ltd

View on ClinicalTrials.gov

Summary

This study aims to evaluate the clinical applicability of the AI-based lightweight ECG monitoring system (MEMO Patch Plus) as a telemetry ECG monitoring system in patients undergoing cardiac surgery. Participants will wear the MEMO Patch Plus for at least 48 hours and up to 168 hours after transfer from the intensive care unit to the general ward. The study will evaluate real-time ECG transmission, arrhythmia detection, device usability, and safety to generate preliminary evidence supporting future clinical studies.

Official title: Evaluation the Lightweight ECG Monitoring System Based on Al as a Telemetry ECG Monitoring System

Key Details

Gender

All

Age Range

19 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

18

Start Date

2022-09-28

Completion Date

2023-11-30

Last Updated

2026-07-24

Healthy Volunteers

No

Interventions

DEVICE

MEMO Patch

The MEMO Patch Plus is a wearable adhesive ECG monitoring device for continuous cardiac rhythm monitoring. The device continuously acquires single-channel ECG signals and wirelessly transmits the data to a remote monitoring system, enabling real-time ECG monitoring and arrhythmia detection by healthcare professionals. The device is intended for continuous cardiac rhythm monitoring in hospitalized patients.

Locations (1)

Korea University Anam Hospital

Seoul, South Korea